Education
About Us
Working with TipRanks
Follow Us
Diagnos Inc (TSE:ADK)
:ADK
ADK Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.43
Previous CloseN/A
Volume270.50K
Average Volume (3M)114.33K
Market Cap
C$20.37M
Enterprise ValueC$25.13M
Total Cash (Recent Filing)C$2.82M
Total Debt (Recent Filing)C$3.29M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding101,862,976
10 Day Avg. Volume155,425
30 Day Avg. Volume114,331
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)-214.66
Price to Sales (P/S)0.00
P/FCF Ratio-11.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Diagnos News
PremiumCompany Announcements
Diagnos Strengthens US Market Position with New Advisory Board Member
PremiumCompany Announcements
Diagnos Inc. Strengthens US Market Strategy with New Advisory Board Member
PremiumCompany Announcements
DIAGNOS Engages Allele Capital for Strategic Advisory
PremiumCompany Announcements
Diagnos Inc. Extends Convertible Debentures Maturity Date
PremiumCompany Announcements
DIAGNOS Achieves Cybersecurity Milestone for CARA System
PremiumCompany Announcements
Diagnos Inc. Announces Amendment to Convertible Debentures
PremiumCompany Announcements
Diagnos’ CARA System License Application Advances with Health Canada
PremiumCompany Announcements
Diagnos Inc. Amends Convertible Debentures TermsOptions Prices
Currently, No data available
---
Ownership Overview
2.50% Insiders
―
Mutual Funds
0.29% Other Institutional Investors
97.21% Public Companies and
Individual Investors
ADK FAQ
What was Diagnos Inc’s price range in the past 12 months?
Diagnos Inc lowest stock price was C$0.18 and its highest was C$0.43 in the past 12 months.
What is Diagnos Inc’s market cap?
Diagnos Inc’s market cap is C$20.37M.
When is Diagnos Inc’s upcoming earnings report date?
Diagnos Inc’s upcoming earnings report date is Aug 21, 2025 which is in 65 days.
How were Diagnos Inc’s earnings last quarter?
Diagnos Inc released its earnings results on May 28, 2025. The company reported -C$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.013.
Is Diagnos Inc overvalued?
According to Wall Street analysts Diagnos Inc’s price is currently Overvalued.
Does Diagnos Inc pay dividends?
Diagnos Inc does not currently pay dividends.
What is Diagnos Inc’s EPS estimate?
Diagnos Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos Inc have?
Diagnos Inc has 101,862,976 shares outstanding.
What happened to Diagnos Inc’s price movement after its last earnings report?
Diagnos Inc reported an EPS of -C$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Diagnos Inc?
Currently, no hedge funds are holding shares in TSE:ADK
Diagnos Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$12.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.50%
12-Months-Change
Fundamentals
Return on Equity
366.78%
Trailing 12-Months
Asset Growth
447.78%
Trailing 12-Months
Company Description
Diagnos Inc
Diagnos (ADK) is a technology company specializing in healthcare solutions, primarily focusing on the development and deployment of artificial intelligence (AI) tools for the early detection and management of critical health conditions. The company's core product is its proprietary AI platform, which leverages advanced algorithms to analyze medical data and assist healthcare providers in diagnosing diseases more accurately and efficiently. Diagnos operates mainly within the healthcare and technology sectors, providing innovative solutions to enhance patient care outcomes.
Technical Analysis
Aiml Resources
―
Treatment.com International
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―